Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.44 |
| ▸ | TLR2 | O60603 | 4/20 | 0.37 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NMT2 | O60551 | 1/20 | 0.32 |
| ▸ | NMT1 | P30419 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29467628 | 0.86 | GLP1R (0.47) | GLP1RTLR2CAPN1CA1CA2 | |
| SCHEMBL29467696 | 0.86 | GLP1R (0.46) | GLP1RTLR2SIRT6SIRT1NMT2 | |
| SCHEMBL30408925 | 0.83 | GLP1R (0.42) | GLP1RTLR2CAPN1CA1CA2 | |
| SCHEMBL23451329 | 0.82 | DPP7 (0.40) | GLP1RTLR2 | |
| SCHEMBL29467697 | 0.82 | DPP7 (0.40) | GLP1RTLR2 | |
| SCHEMBL23451330 | 0.82 | DPP7 (0.40) | GLP1RTLR2 | |
| SCHEMBL30406580 | 0.81 | GLP1R (0.47) | GLP1RTLR2CAPN1CA1CA2 | |
| SCHEMBL30407101 | 0.81 | GLP1R (0.49) | GLP1RTLR2CAPN1TDP1 | |
| SCHEMBL23451364 | 0.80 | GLP1R (0.44) | GLP1RCAPN1CA1CA2 | |
| SCHEMBL23451366 | 0.80 | GLP1R (0.44) | GLP1RCAPN1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4426729-A1 | SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE | Hangzhou Dac Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
| WO-2023078273-A1 | SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-05-11 | — | — | WO | disclosed |